These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 39366195)
1. Chemotherapy and allo-HSCT for young patients with aggressive ATL. Fuji S Leuk Res; 2024 Dec; 147():107596. PubMed ID: 39366195 [TBL] [Abstract][Full Text] [Related]
2. The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. Kawano N; Kuriyama T; Yoshida S; Kawano S; Yamano Y; Marutsuka K; Minato S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Kikuchi I J Clin Exp Hematop; 2017; 56(3):135-144. PubMed ID: 28331127 [TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience. Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158 [TBL] [Abstract][Full Text] [Related]
4. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia. Kamiunten A; Sekine M; Kameda T; Akizuki K; Tahira Y; Shide K; Shimoda H; Kato K; Hidaka T; Kubuki Y; Shimoda K Hematol Oncol; 2018 Oct; 36(4):651-655. PubMed ID: 30117169 [TBL] [Abstract][Full Text] [Related]
5. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab]. Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802 [TBL] [Abstract][Full Text] [Related]
6. Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality. Fuji S; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Choi I; Otsuka E; Henzan H; Kato K; Tomoyose T; Yamamoto H; Kurosawa S; Matsuoka K; Yamaguchi T; Fukuda T J Clin Oncol; 2016 Oct; 34(28):3426-33. PubMed ID: 27507878 [TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202 [TBL] [Abstract][Full Text] [Related]
9. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. Katsuya H; Ishitsuka K J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744 [TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma. Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883 [TBL] [Abstract][Full Text] [Related]
11. Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation. Tokunaga M; Uto H; Takeuchi S; Nakano N; Kubota A; Tokunaga M; Takatsuka Y; Seto M; Ido A; Utsunomiya A Leuk Lymphoma; 2017 Jan; 58(1):37-44. PubMed ID: 27654808 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience. Fukushima T; Taguchi J; Moriuchi Y; Yoshida S; Itonaga H; Ando K; Sawayama Y; Imaizumi Y; Imanishi D; Hata T; Miyazaki Y Int J Hematol; 2011 Oct; 94(4):390-394. PubMed ID: 21960057 [TBL] [Abstract][Full Text] [Related]
13. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation. Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226 [TBL] [Abstract][Full Text] [Related]
14. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012). Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237 [TBL] [Abstract][Full Text] [Related]
15. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation. Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749 [TBL] [Abstract][Full Text] [Related]
16. [Impact of pretransplant anti-CCR4 antibody administration on clinical outcomes in allogeneic hematopoietic stem cell transplantation]. Fuji S Rinsho Ketsueki; 2019; 60(8):968-972. PubMed ID: 31484897 [TBL] [Abstract][Full Text] [Related]
17. Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience. Sakamoto H; Itonaga H; Sawayama Y; Furumoto T; Fujioka M; Chiwata M; Toriyama E; Kasai S; Nakashima J; Horai M; Kato T; Sato S; Ando K; Taguchi J; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Miyazaki Y Hematol Oncol; 2020 Apr; 38(2):162-170. PubMed ID: 31922287 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy. Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China. Luo L; Jiao Y; Li Y; Yang P; Gao J; Huang S; Huang W; Wang J; Dong F; Ke X; Zou D; Gao C; Jing H Ann Hematol; 2024 Jun; 103(6):2073-2087. PubMed ID: 38581546 [TBL] [Abstract][Full Text] [Related]